News


BGP advises on the execution of an international sales and trade finance transaction

20. November 2020

Bader Gnehm & Partner advises an international foreign oil and gas company on the execution of a transcontinental sale of an oil drilling rig. The complex deal was executed under Swiss law und involved industry and trade finance parties across several jurisdictions.

The seller and exporter was advised in all Swiss legal matters regarding the execution by Bader Gnehm & Partner. The team was led by Michael Bader (Senior Partner) and furthermore involved were Oliver Gnehm (Partner) and Olivier Bula (Partner).

Bader Gnehm & Partner’s Trade & Export Finance team features experienced specialists delivering comprehensive legal and negotiation services to market players and industries involved in international commerce, trade and export finance.

More information can be found here


BGP advises Memo Therapeutics regarding its CHF 14 Mio. Series B financing round

11. November 2020

Bader Gnehm & Partner advised Memo Therapeutics Ltd in a CHF 14 million Series B financing round, involving the investors Swisscanto Invest, BERNINA BioInvest, Redalpine, Jaquet Partners and Schroder Adveq.

Memo Therapeutics Ltd, an innovator in the field of antibody discovery and immune repertoire analysis, intends to use the proceeds to further develop its lead antibody candidate "MTX-COVAB" for the treatment of COVID-19.

 

Memo Therapeutics Ltd was advised in all legal matters with regard to the Series B financing round by Bader Gnehm & Partner. The team consisted of Oliver Gnehm (Partner), Denis A. Parvex (Associate) and Thomas Gysin (Associate).

Bader Gnehm & Partner has been repeatedly awarded as top law firm in the area of "Private Equity and Venture Capital".

The press release of Memo Therapeutics Ltd can be found here. 


Araris Biotech raises CHF 15.2 mio in Seed financing round

06. November 2020

Araris Biotech Ltd has obtained CHF 15.2 million in a Seed financing round from the investors Pureos Bioventures, 4BIO Capital, btov Partners, Redalpine, VI Partners and Schroder Adveq.

Araris Biotech Ltd, a company pioneering antibody-drug conjugate (ADC)-linker technology, intends to use the proceeds to support advancement of lead ADCs into preclinical and clinical development. 

 

 

Araris Biotech Ltd was advised in all legal matters with regard to the Seed financing round by Bader Gnehm & Partner. The team consisted of Oliver Gnehm (Partner), Denis A. Parvex (Associate) and Thomas Gysin (Associate).

Bader Gnehm & Partner has been repeatedly awarded as top law firm in the area of "Private Equity and Venture Capital".

The press release of Araris Biotech Ltd can be found here: Araris Biotech


BGP Berne is moving

12. October 2020

We are moving into new premises in the Länggasse!

As of 5 October 2020 you will find our Berne office at Länggassstrasse 10, 3012 Bern.

We kindly ask you to use our new mailing address from now on. Our phone and fax numbers as well as e-mail addresses remain unchanged.


Trade & Export Finance

13. July 2020

Bader Gnehm & Partner advised a Swiss exporter of disaster control equipment in the negotiation and conclusion of a complex, multi-staged sale and purchase transaction involving letter of credits, performance guarantees and several international parties, including inter alia a Swiss bank and a Chinese purchaser.

The Swiss exporter was advised in all legal matters by Bader Gnehm & Partner. The team was led by Oliver Gnehm (Partner) and furthermore included Denis A. Parvex (Associate).

Bader Gnehm & Partner’s Trade & Export Finance team features experienced specialists delivering comprehensive legal and negotiation services to market players and industries involved in international commerce, trade and export finance.

More information can be found here.

1 2 3 4 5 6 7 8 9 10 11 12 13 14